Leukosite, Inc.
Records under this name other than patents Leukosite, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,147,851 | Humanized immunoglobulin reactive with α4β7 integrin Formerly held Term ended Term ended Sep 27, 2021 · From the USPTO record | Term ended | Term ended Sep 27, 2021 | From the USPTO record |
| US 6,294,560 | Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof Formerly held Term ended Term ended Jun 20, 2020 · From the USPTO record | Term ended | Term ended Jun 20, 2020 | From the USPTO record |
| US 7,803,904 | Mucosal vascular addressing and uses thereof Formerly held Term ended Term ended Jun 11, 2020 · From the USPTO record | Term ended | Term ended Jun 11, 2020 | From the USPTO record |
| US 6,297,217 | Boronic ester and acid compounds, synthesis and uses Formerly held Term ended Term ended Jan 25, 2020 · From the USPTO record | Term ended | Term ended Jan 25, 2020 | From the USPTO record |
| US 6,306,895 | Substituted oxygen alicyclic compounds, including methods for synthesis thereof Formerly held Term ended Term ended Jul 2, 2019 · From the USPTO record | Term ended | Term ended Jul 2, 2019 | From the USPTO record |
| US 6,310,221 | Methods for synthesis of substituted tetrahydrofuran compound Formerly held Term ended Term ended Jul 2, 2019 · From the USPTO record | Term ended | Term ended Jul 2, 2019 | From the USPTO record |
| US 6,433,197 | Substituted Oxygen Alicyclic Compounds, Including Methods for Synthesis Thereof Formerly held Term ended Term ended Jul 2, 2019 · Medium confidence | Term ended | Term ended Jul 2, 2019 | Medium confidence |
| US 6,541,647 | Methods for Synthesis of Substituted Tetrahydrofuran Compound Formerly held Term ended Term ended Jul 2, 2019 · Medium confidence | Term ended | Term ended Jul 2, 2019 | Medium confidence |
| US 6,451,301 | Analgesic and antinociceptive methods Formerly held Term ended Term ended Jun 7, 2019 · From the USPTO record | Term ended | Term ended Jun 7, 2019 | From the USPTO record |
| US 6,329,159 | Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function Formerly held Term ended Term ended Mar 11, 2019 · From the USPTO record | Term ended | Term ended Mar 11, 2019 | From the USPTO record |